A fungus that has killed millions of bats across North America has arrived in Arizona, state wildlife officials announced on ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Irish Star on MSN1d
Elon Musk calls judge 'evil' after court orders Trump to restore CDC and health websitesElon Musk called the federal judge 'evil' and insisted that he be immediately fired after he ordered the restoration of ...
During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed goals and barriers to treatment when using ...
GlobalData on MSN1d
SmartCella gains rights to advance cell therapy research for Parkinson’sThe company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...
The threat of grapevine pests and diseases is a constant battle, but research driven by the Pierce’s Disease and Glassy-Winged ...
Loss of dopaminergic neurons in the substantia nigra and accumulation of α-synuclein (α-Syn) aggregates are the major hallmarks of Parkinson’s disease (PD).
AI predicts Parkinson’s disease using medical and prescription data, enhancing early diagnosis and research into new ...
AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...
At Week 14, 69% (71% of b/tsDMARD-naïve and 66% of b/tsDMARD-experienced) or 220 of the 318 rosnilimab-treated patients across all doses achieved CDAI LDA and were eligible to remain on continued ...
Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback